Driven to restore Movement Function Independence
in people with spinal cord injury
ARCEX Therapy
ARCEX Therapy
Targeted stimulation of the spinal cord intended to improve hand sensation and strength after spinal cord injury, delivered via our external ARCEX System.
Targeted stimulation of the spinal cord intended to improve hand sensation and strength after spinal cord injury, delivered via our external ARCEX System.
Investigational, targeted stimulation of the spinal cord designed to restore movement and other critical functions after spinal cord injury, delivered via our implantable ARCIM System.
Investigational, targeted stimulation of the spinal cord designed to restore movement and other critical functions after spinal cord injury, delivered via our implantable ARCIM System.
The ONWARD® Medical ARCEX® System is cleared for use only in the United States. The ARCEX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.